Literature DB >> 3875855

Evidence for the involvement of the submandibular gland epidermal growth factor in mouse mammary tumorigenesis.

H Kurachi, S Okamoto, T Oka.   

Abstract

The submandibular gland is a rich source of epidermal growth factor (EGF) in mice. The concentration of EGF in the gland of virgin female mice of C3H/HeN strain increased as much as 9-fold from the age of 30 to 52 weeks. During this period, the incidence of mammary tumor in virgin females increased markedly to a maximal level of 62.5% (n = 48) at 52 weeks of age. Removal of the submandibular gland (sialoadenectomy) of virgin mice 14-22 weeks old reduced the tumor incidence to 12.8% (n = 39) at the age of 52 weeks and also increased the latency period of mammary tumor development as much as 14 weeks when compared to that of normal mice. Long-term treatment of sialoadenectomized virgin mice with EGF (5 micrograms per mouse every other day) increased the tumor incidence to 33.3%. Moreover, sialoadenectomy of mammary tumor-bearing animals caused a rapid and sustained cessation of tumor growth, but EGF administration (5 micrograms per mouse per day) quickly restored the rate of tumor growth to a normal level. These results indicate that submandibular gland EGF plays a crucial role in mouse mammary tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875855      PMCID: PMC390669          DOI: 10.1073/pnas.82.17.5940

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Recent studies of the hormonal influence in mouse mammary tumorigenesis.

Authors:  H A BERN; S NANDI
Journal:  Prog Exp Tumor Res       Date:  1961

Review 2.  The regulation of cell proliferation: advances in the biology and mechanism of action of epidermal growth factor.

Authors:  G Carpenter
Journal:  J Invest Dermatol       Date:  1978-11       Impact factor: 8.551

3.  Stimulation of mammary carcinoma cell proliferation by epithelial growth factor in vitro.

Authors:  R W Turkington
Journal:  Cancer Res       Date:  1969-07       Impact factor: 12.701

4.  Evidence for physiological function of epidermal growth factor: pregestational sialoadenectomy of mice decreases milk production and increases offspring mortality during lactation period.

Authors:  S Okamoto; T Oka
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

5.  Epidermal growth factor stimulates cell proliferation and inhibits functional differentiation of mouse mammary epithelial cells in culture.

Authors:  Y Taketani; T Oka
Journal:  Endocrinology       Date:  1983-09       Impact factor: 4.736

6.  Epidermal growth factor requirement for development of cultured mammary gland.

Authors:  Q J Tonelli; S Sorof
Journal:  Nature       Date:  1980-05-22       Impact factor: 49.962

7.  Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor.

Authors:  H Marquardt; M W Hunkapiller; L E Hood; D R Twardzik; J E De Larco; J R Stephenson; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

8.  Tumor promoter 12-O-tetradecanoylphorbol 13-acetate, like epidermal growth factor, stimulates cell proliferation and inhibits differentiation of mouse mammary epithelial cells in culture.

Authors:  Y Taketani; T Oka
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

9.  Nerve growth factor receptors on human melanoma cells in culture.

Authors:  R N Fabricant; J E De Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

10.  Epidermal growth factors enhances viral transformation of granulosa cells.

Authors:  J Harrison; N Auersperg
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

View more
  19 in total

1.  Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.

Authors:  Gouri Chatterjee; Andrea Rosner; Yi Han; Edward T Zelazny; Baolin Li; Robert D Cardiff; Archibald S Perkins
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Chromatin Remodeling in Response to BRCA2-Crisis.

Authors:  Joshua J Gruber; Justin Chen; Benjamin Geller; Natalie Jäger; Andrew M Lipchik; Guangwen Wang; Allison W Kurian; James M Ford; Michael P Snyder
Journal:  Cell Rep       Date:  2019-08-20       Impact factor: 9.423

3.  Epidermal growth factor-like activity and epidermal growth factor-receptors in human primary breast cancer.

Authors:  Z Kahán; M Szücs; M Vecsernyés; S Eckhardt
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  Inhibitory effect of sialoadenectomy on hepatocellular tumourigenesis in male mice induced by 3'-methyl-4-dimethylaminoazobenzene.

Authors:  R Yamamoto; H Iishi; M Tatsuta; M Tsuji; N Terada
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate.

Authors:  E Kordon; C Lanari; R Meiss; P Elizalde; E Charreau; C Dosne Pasqualini
Journal:  Breast Cancer Res Treat       Date:  1990-11       Impact factor: 4.872

6.  Growth-inhibitory effects of epidermal growth factor on human breast cancer and carcinoma of the esophagus transplanted into nude mice.

Authors:  Y Murayama
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

7.  Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha.

Authors:  K Yoshida; H Kuniyasu; W Yasui; Y Kitadai; T Toge; E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination.

Authors:  K Szepeshazi; S Milovanovic; K Lapis; K Groot; A V Schally
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

9.  Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene.

Authors:  R B Dickson; A Kasid; K K Huff; S E Bates; C Knabbe; D Bronzert; E P Gelmann; M E Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

10.  A Comparison of the Proteomic Expression in Pooled Saliva Specimens from Individuals Diagnosed with Ductal Carcinoma of the Breast with and without Lymph Node Involvement.

Authors:  Charles F Streckfus; Karen A Storthz; Lenora Bigler; William P Dubinsky
Journal:  J Oncol       Date:  2009-12-20       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.